loadpatents
name:-0.035037040710449
name:-0.016655921936035
name:-0.0040309429168701
Greve; Jeffrey Patent Filings

Greve; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greve; Jeffrey.The latest application filed is for "method for treating disease using foxp3+cd4+ t cells".

Company Profile
3.13.28
  • Greve; Jeffrey - Berkeley CA
  • Greve; Jeffrey - Emeryville CA
  • Greve; Jeffrey - Berkeiey CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for treating disease using FOXP3+CD4+ T cells
Grant 11,446,357 - Mahne , et al. September 20, 2
2022-09-20
Method For Treating Disease Using Foxp3+cd4+ T Cells
App 20220169687 - Mahne; Ashley ;   et al.
2022-06-02
A Method For Treating Disease Using Foxp3+cd4+ T Cells
App 20220143134 - Mahne; Ashley ;   et al.
2022-05-12
Method For Treating Disease Using Foxp3+cd4+ T Cells
App 20220110975 - Levinson; Sarah ;   et al.
2022-04-14
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20220112260 - Greve; Jeffrey
2022-04-14
Methods Of Producing T Regulatory Cells, Methods Of Transducing T Cells, And Uses Of The Same
App 20220031751 - Quarmyne; Mamle ;   et al.
2022-02-03
Multivalent Regulatory T Cell Modulators
App 20210403579 - Kim; Jungmin ;   et al.
2021-12-30
Il-2 Variants For The Treatment Of Autoimmune Diseases
App 20210308222 - Greve; Jeffrey
2021-10-07
IL-2 variants for the treatment of psoriasis
Grant 11,077,172 - Greve August 3, 2
2021-08-03
Multivalent regulatory T cell modulators
Grant 11,059,877 - Greve , et al. July 13, 2
2021-07-13
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20210070828 - Greve; Jeffrey
2021-03-11
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20210047382 - Greve; Jeffrey
2021-02-18
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Grant 10,875,901 - Greve December 29, 2
2020-12-29
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Grant 10,774,126 - Greve September 15, 2
2020-09-15
Nucleic acid encoding human IL-2 variant
Grant 10,766,938 - Greve Sep
2020-09-08
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20200115429 - Greve; Jeffrey
2020-04-16
Multivalent Regulatory T Cell Modulators
App 20200031897 - Greve; Jeffrey ;   et al.
2020-01-30
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20190375812 - Greve; Jeffrey
2019-12-12
Multivalent regulatory T cell modulators
Grant 10,472,405 - Greve , et al. Nov
2019-11-12
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20190202881 - Greve; Jeffrey
2019-07-04
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20190202882 - Greve; Jeffrey
2019-07-04
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20190153058 - Greve; Jeffrey
2019-05-23
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Grant 10,294,287 - Greve
2019-05-21
Modified IL-2 variants that selectively activate regulatory T cells
Grant 10,035,836 - Greve July 31, 2
2018-07-31
Multivalent Regulatory T Cell Modulators
App 20180162919 - Greve; Jeffrey ;   et al.
2018-06-14
IL-2 Variants for the Treatment of Autoimmune Diseases
App 20180125941 - Greve; Jeffrey
2018-05-10
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20180037624 - Greve; Jeffrey
2018-02-08
PEGylated aspartyl-tRNA synthetase polypeptides
Grant 9,822,353 - Buechler , et al. November 21, 2
2017-11-21
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20170327555 - Greve; Jeffrey
2017-11-16
Aspartyl-tRNA synthetases
Grant 9,816,084 - Buechler , et al. November 14, 2
2017-11-14
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20170204154 - Greve; Jeffrey
2017-07-20
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20170051029 - GREVE; Jeffrey
2017-02-23
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases
App 20170037102 - GREVE; Jeffrey
2017-02-09
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
App 20160369259 - Chiang; Kyle P. ;   et al.
2016-12-22
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
Grant 9,273,302 - Chiang , et al. March 1, 2
2016-03-01
Pegylated Aspartyl-trna Synthetase Polypeptides
App 20150159148 - Buechler; Ying Ji ;   et al.
2015-06-11
Histidyl-trna Synthetases For Treating Autoimmune And Inflammatory Diseases
App 20150093799 - Chiang; Kyle P. ;   et al.
2015-04-02
Aspartyl-trna Synthetases
App 20140302075 - Buechler; Ying Ji ;   et al.
2014-10-09
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
Grant 8,835,387 - unknownunknownChiang , et al. September 16, 2
2014-09-16
Histidyl-trna Synthetases For Treating Autoimmune And Inflammatory Diseases
App 20130344096 - Chiang; Kyle P. ;   et al.
2013-12-26
T-cell selective interleukin-4 agonists
App 20030004314 - Shanafelt, Armen B. ;   et al.
2003-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed